Limited Time Sale$108.34 cheaper than the new price!!
| Management number | 204570045 | Release Date | 2025/10/14 | List Price | $88.65 | Model Number | 204570045 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Dexmedetomidine Hydrochloride Injection is a potent, selective alpha-2 adrenergic agonist used in dogs and cats for sedation and analgesia during clinical procedures or minor surgeries. Commonly used in veterinary practices, this injectable agent provides reliable sedation, muscle relaxation, and pain control, allowing safe handling of animals for diagnostic or therapeutic interventions. Its effects are dose-dependent and reversible with atipamezole, making it highly versatile in veterinary anesthetic protocols. Dexmedetomidine offers a rapid onset, a predictable duration, and is suitable for use in both healthy and select high-risk patients when administered by a veterinary professional.
It can be administered intramuscularly (IM) or intravenously (IV) depending on the required onset time and procedure duration. Always follow the veterinarian’s dosing guidelines.
While generally safe when used as directed, Dexmedetomidine should be used cautiously in pets with cardiac disease, respiratory compromise, or liver dysfunction. It is not recommended for use in pregnant or lactating animals.
It is a sedative and analgesic used for restraint, sedation, and minor surgical or diagnostic procedures in dogs and cats.
It is an alpha-2 adrenergic agonist that induces sedation and pain relief by decreasing norepinephrine release in the central nervous system.
It can be used alone or in combination with other agents, such as opioids or ketamine, for pre-anesthetic sedation or procedural sedation.
It is typically administered intramuscularly (IM) or intravenously (IV), with dosage based on body weight and species-specific protocols.
Side effects may include bradycardia, hypotension, vomiting, and respiratory depression. Close monitoring is required during and after administration.
Sedation typically begins within 5–15 minutes and may last 30–60 minutes, depending on dose and administration route.
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form